MAP3K8 and neoplasm: Studies in human tumor specimens have shown that Tpl2/Cot is overexpressed in early stage breast cancer [9], in EBV-related Hodgkin lymphomas and nasopharyngeal carcinomas [10] and occasionally in gastric and colon adenocarcinomas [11].